Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer Prognosis

$ 23.99

4.5
(287)
In stock
Description

Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.

Bidirectional Crosstalk between the Estrogen Receptor and Human

Cancers, Free Full-Text

Frontiers Characteristics and survival in bone metastatic breast

The Clinical and Biological Significance of Estrogen Receptor-Low

Hormone Therapy for Breast Cancer: What to Know

Combined quantitative measures of ER, PR, HER2, and KI67 provide

Understanding Your Pathology Report: Breast Cancer

Updates in endocrine therapy for metastatic breast cancer

Cells, Free Full-Text

Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive

Early Diagnosis and Treatment of Cancer by juan jaramillo - Issuu

IJMS, Free Full-Text

Targeting steroid hormone receptors for anti‐cancer therapy—A

Eribulin Treatment Promotes Re-expression of Estrogen Receptor in